French expenditure on reimbursable devices continues double-digit rise
This article was originally published in Clinica
Executive Summary
The amount reimbursed by the French social security for medical products generally intended for direct use by individual patients in 2001 was E2,989bn ($2,800bn) compared with was some E2.7bn in 2000, an increase of 13%. This is an improvement compared with the average rate of some 15% over between 1998 and 2000, but is still much higher than the increase in the overall healthcare expenditure budget, which was set at 3.5% for 2001 and means that it will undoubtedly be targeted for cuts by the new government.